Sub-Q Bionics
PrivateLast Round
Pre Seed
Mar 31, 2026
Total Funding Raised
$3M
Company Overview
Sub-Q Bionics is a medical technology company developing an implantable lymphatic drainage system to manage lymphedema, a chronic condition often experienced by cancer survivors.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Health IoT, Clinical Trials
Business Model
B2B
Customer Profile
Hardware Sales, Hardware + Subscription, Government Contracts
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Sub-Q Bionics Comps
Public and private peers based on sector, stage, and business model.
Sub-Q Bionics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Pre Seed | Mar 31, 2026 | ||||
| Pre Seed | Mar 31, 2026 |
Key People
Founding team and executive leadership
Sub-Q Bionics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Israel Innovation Authority | Pre Seed |
| Mayo Clinic Ventures | Pre Seed |
| Yeda Research and Development Company Ltd. | Pre Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Mar 31, 2026
$1.5M raised in Pre Seed round.
- Mar 31, 2026
$1.5M raised in Pre Seed round.
Sub-Q Bionics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Sub-Q Bionics's valuation, stock price, and market status.
